These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9511437)

  • 21. [Gastroduodenal functional disorders].
    Guevara L
    Rev Invest Clin; 1971; 23(3):221-35. PubMed ID: 5133220
    [No Abstract]   [Full Text] [Related]  

  • 22. [Lipid spectrum of the blood serum and feces in children with gastroduodenal pathology].
    Khamraev AKh; Rustamov MR; Radzhabov NA
    Pediatriia; 1988; (10):109. PubMed ID: 3222076
    [No Abstract]   [Full Text] [Related]  

  • 23. [NSAID-gastropathy: state-of-the-art therapy optimization capabilities in outpatient practice].
    Burkov SG; Arutiunov AT; Gurova NIu; Lobanova EG; Nikiforov PA; Okoemov MN; Cherezova IN; Chugunnikova LI
    Eksp Klin Gastroenterol; 2008; (3):97-101. PubMed ID: 19145889
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative study of the changes in blood gastrin, insulin, and glucose in non-steroidal anti-inflammatory agent-induced gastroduodenal diseases treated with prostaglandin analogs of the E2 series].
    Melloni GF; Scarazatti E; Fiorenza AM; Melloni CF
    Boll Soc Ital Biol Sper; 1987 Nov; 63(11):1035-41. PubMed ID: 3331287
    [No Abstract]   [Full Text] [Related]  

  • 25. [Correlation between mucoproteins and mucoporteoses of the gastric juice in adolescents with chronic diseases of the stomach].
    Gorbunova NA
    Pediatriia; 1971 May; 50(5):19-22. PubMed ID: 5122483
    [No Abstract]   [Full Text] [Related]  

  • 26. [The nervous system and the gastroduodenal ulcer. Its treatment using autonomic drugs. 3. Nervous system and therapy of the ulcer].
    Martinez Romero A
    Rev Esp Enferm Apar Dig; 1969; 29(2):265-88. PubMed ID: 5811495
    [No Abstract]   [Full Text] [Related]  

  • 27. [Oxygen metabolism disturbances in the pathogenesis of gastric and duodenal diseases].
    Swiatkowski M; Budzyński J; Kłopocka M; Suppan K
    Przegl Lek; 1999; 56(3):220-6. PubMed ID: 10442013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of gastroduodenal reflux in the formation of gastroduodenal pathology].
    Uspenskiĭ VM; Grinevich VB
    Ter Arkh; 1980; 52(2):44-8. PubMed ID: 7376096
    [No Abstract]   [Full Text] [Related]  

  • 29. [Gastroduodenal complications of amebiasis].
    Duriez R; Fromantin M; Boisselier P; Gautier D; Gasc A
    Lyon Med; 1971 Apr; 225(8):743-7. PubMed ID: 5577909
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prevalence of polyresistance to antibiotics among Helicobacter pylori strains isolated from patients with gastroduodenal zone diseases].
    Khetsuriani ShG; Rachvelishvili BKh; Khetsuriani KG
    Ter Arkh; 2006; 78(2):19-21. PubMed ID: 16613090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A method for the conservative treatment of patients with erosive and ulcerative lesions in the oesophagogastroduodenal system with the use of spa factors and medications. A new medical technology].
    Osipov IuS; Efimenko NV; Uvarova NG; Kaĭsinova AS; Ereshova IG; Mosiiants LM; Fedorova TE; Chubina IA
    Vopr Kurortol Fizioter Lech Fiz Kult; 2008; (5):49-51. PubMed ID: 19069812
    [No Abstract]   [Full Text] [Related]  

  • 32. Ghrelin and the cardiovascular system.
    Tokudome T; Kishimoto I; Miyazato M; Kangawa K
    Front Horm Res; 2014; 43():125-33. PubMed ID: 24943303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mediator content of the rat brain in neurogenic gastric pathology].
    Zavodskaia IS; Bul'on VV; Moreva EV
    Biull Eksp Biol Med; 1984 Feb; 97(2):135-6. PubMed ID: 6141824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gastroduodenal intussusception causing gastric retention].
    Alamili M; Berg JO; Lindström C; Jensen CV; Wettergren A
    Ugeskr Laeger; 2008 Feb; 170(9):753. PubMed ID: 18307965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on a new protective agent of gastro-duodenal mucous membrane].
    Sardet MB; Ruas J
    J Med Bord; 1967 Aug; 144(8):1188-97. PubMed ID: 5619385
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of a new synthetic cholerectic agent in the therapy of some gastro-duodeno-biliary and pancreatic diseases].
    Azzena D
    Clin Ter; 1972 Apr; 61(1):47-58. PubMed ID: 5039601
    [No Abstract]   [Full Text] [Related]  

  • 37. [Letter: Duodenogastric reflux].
    Ottenjann R
    Dtsch Med Wochenschr; 1975 Apr; 100(14):779. PubMed ID: 1126287
    [No Abstract]   [Full Text] [Related]  

  • 38. [Central mechanisms of neurogenic gastric lesion and its pharmacologic correction].
    Bul'on VV
    Patol Fiziol Eksp Ter; 1995; (1):21-3. PubMed ID: 7609999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pyloric Campylobacter and esophago-gastroduodenal pathology].
    León-Barua R
    Acta Gastroenterol Latinoam; 1985; 15(2):129-31. PubMed ID: 3835764
    [No Abstract]   [Full Text] [Related]  

  • 40. [Ambulant treatment of inflammatory and ulcerous diseases of the stomach and duodenum with a complex stomach preparation].
    Friedrich R
    Med Welt; 1965 Jul; 29():1663-5. PubMed ID: 5318490
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.